Revance Therapeutics Inc.

(RVNC) Trade

By |

Profile

Revance Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.

Contact Information

Website: www.revance.com
Email: contacts@revance.com
Main Phone: +1 510 742-3400
Address: 7555 Gateway Boulevard
State: CA
City / Town: Newark
Country: USA
Postal Code: 94560

Issuer Information

Exchange: NSD
CEO: L. Daniel Browne
Employees: 136
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 28.85 $ 0.05 (0.17%)
Last Price 28.85 Change $ 0.05 Change % 0.17 Tick N/A
Bid 26.00 Bid Size 100.00 Ask 32.00 Ask Size 100.00
Open 28.70 High 29.00 Low 28.35 Prev Close 28.80
Last Trade Volume 198,373 52 Wk Hi 37.45 52 Wk Low 22.05
Market Cap 1.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 36,783,896.00 EPS (TTM) -4.03 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 23 57
Number of Buys 16 34
Number of Sells 7 23
Net Activity 66359 165621
Last 10 Buys Shares
Philip J. Vickers 1,000
Philip J. Vickers 1,000
Mark J. Foley 1,000
Mark J. Foley 1,000
Lauren P. Silvernail 1,000
Lauren P. Silvernail 1,000
L. Daniel Browne 1,000
Last 10 Sell Shares
Lauren P. Silvernail 1,000
Lauren P. Silvernail 1,000
Phyllis I. Gardner 1,000
L. Daniel Browne 1,000
L. Daniel Browne 1,000
Lauren P. Silvernail 1,000
Lauren P. Silvernail 1,000
L. Daniel Browne 1,000
Lauren P. Silvernail 1,000
L. Daniel Browne 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 58 58 58 58
Low Target Price Estimate 34 34 34 34
Mean Target Price Estimate 47.38 47.38 47.38 47.38
Standard Deviation 7.76 7.76 7.76 7.76
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 7 7
Moderate Buy 1 1 1 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.33 1.33 1.25